Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeto develops and commercializes FDA-cleared wireless EEG headsets with dry electrodes and a cloud-based AI-enabled platform for rapid, remote neurodiagnostic assessment. Their solutions are used across hospitals, emergency departments, ICUs, ambulances, outpatient clinics, research labs and at home. The system enables real-time data streaming to neurologists for interpretation and offers AI-powered seizure detection. Over two hundred US healthcare facilities use their products. Clinical results highlight improved access to timely EEGs—especially where trained technologists are scarce—and faster diagnosis of neurological emergencies such as status epilepticus or subclinical seizures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeto.